Wyss InstituteChemistry – Wyss Institute

Eliz Amar Lewis on Using Many Tools to Fight a Sophisticated Disease

Jessica Leff — Tue, 24 Sep 2024 14:50:19 +0000

The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as professionals, and their collaborations at the Wyss Institute and beyond. Eliz Amar Lewis has always been fascinated by biology. But when she saw her grandmother bravely battle breast cancer, she was inspired to use her passion to develop a smart and sophisticated…

Source

AminoX: Making Better Protein Drugs, Quicker and Cheaper

Jessica Leff — Wed, 10 Jul 2024 13:56:00 +0000

A synthetic biology and advanced chemistry platform that efficiently incorporates non-standard amino acids by hacking the ubiquitous protein synthesis process. Credit: Wyss Institute at Harvard University…

Source

AminoX: Making Better Protein Drugs, Quicker and Cheaper

Jessica Leff — Wed, 01 May 2024 15:40:43 +0000

Protein drugs often offer the most effective way to treat a variety of medical illnesses and conditions. However, many proteins in their naturally occurring forms make poor drugs – they can cause toxicities that force patients to discontinue treatment, and they often have such short half-lives that patients would need to receive a constant infusion of them to see a therapeutic effect. Recently…

Source

Emily Stoler on Developing Sustainable Solutions

Jessica Leff — Mon, 22 Apr 2024 16:01:24 +0000

The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as professionals, and their collaborations at the Wyss Institute and beyond. When Emily Stoler was eighteen years old, she described her dreams for the future to a taxi driver. Now, after studying chemistry and working across academia and industry…

Source

A new glue, potentially also for you

Jessica Leff — Tue, 20 Feb 2024 15:50:09 +0000

By Benjamin Boettner (BOSTON) — Hydrogels are versatile biomaterials conquering an increasing number of biomedical areas. Consisting of water-swollen molecular networks that can be tailored to mimic the mechanical and chemical features of various organs and tissues, they can interface within the body and on its outer surfaces without causing any damage to even the most delicate parts of the…

Source

Bogdan Budnik on Analyzing Proteins to Develop Better Diagnostics and Therapeutics

Jessica Leff — Thu, 15 Feb 2024 14:50:30 +0000

The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as professionals, and their collaborations at the Wyss Institute and beyond. After studying physics for many years, Bogdan Budnik realized instead of using his knowledge to generate power, he wanted to use it to empower people with better disease diagnostics and…

Source

Advancing precision diagnostics at the patient point-of-care

Jessica Leff — Thu, 08 Feb 2024 15:55:59 +0000

By Benjamin Boettner (BOSTON) — Aging populations and the tendency to lead a more sedentary lifestyle in many parts of the world is thought to dramatically increase the numbers of people living with multiple, chronic conditions. Moreover, climate change, as well as shifting patterns in land-use and travel, keep increasing the risk of infectious diseases that can emerge and spread locally and…

Source

Highly Cited Researchers 2023 honors 13 Wyss faculty members

Jessica Leff — Wed, 15 Nov 2023 14:00:32 +0000

By Lindsay Brownell (BOSTON) — Today, Clarivate Analytics announced its annual Highly Cited Researchers 2023 list, which honors the top 1% of researchers around the world whose papers have been cited the most in the previous 10 years. Clarivate uses both quantitative and qualitative analyses to identify individuals who have demonstrated significant and broad influence in their chosen field(s)…

Source

Coming together to engineer new treatments for serious diseases

Jessica Leff — Mon, 23 Oct 2023 17:14:48 +0000

By Jessica Leff Immunotherapy is often seen as the next frontier in cancer treatment, offering many benefits over traditional therapies like radiation and chemotherapy. Unfortunately, immunotherapy patients frequently experience painful side effects because antibodies affect healthy tissues along with the tumor. What if these drugs could more accurately target cancer cells…

Source

Wyss Institute at Harvard University partners with Northpond Labs to launch RNA solutions company EnPlusOne Biosciences

Jessica Leff — Mon, 19 Dec 2022 13:55:10 +0000

By Benjamin Boettner (BOSTON) — Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University and EnPlusOne Biosciences (EnPlusOne Bio) announced that the startup company has signed a worldwide, exclusive licensing agreement with Harvard’s Office of Technology Development (OTD) that grants EnPlusOne Bio the rights to commercialize a novel…

Source